AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 151 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,000 | -78.6% | 200 | -80.0% | 0.00% | -80.0% |
| Q4 2016 | $42,000 | -20.8% | 1,000 | 0.0% | 0.01% | -28.6% |
| Q3 2016 | $53,000 | +26.2% | 1,000 | -1.4% | 0.01% | +16.7% |
| Q2 2016 | $42,000 | -26.3% | 1,014 | -28.3% | 0.01% | -40.0% |
| Q1 2016 | $57,000 | -74.6% | 1,414 | -29.8% | 0.02% | -75.0% |
| Q2 2015 | $224,000 | +17.9% | 2,014 | 0.0% | 0.08% | +8.1% |
| Q1 2015 | $190,000 | -15.2% | 2,014 | +0.7% | 0.07% | -24.5% |
| Q4 2014 | $224,000 | – | 2,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |